George Simeon
SEC Form 4 insider trading activity
George Simeon has filed 2 SEC Form 4 filings (11 transaction rows) across 2 companies, including CRSP, ADRX, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Oct 16, 2026.
On the most recent filing, George Simeon is listed as Director at CRISPR Therapeutics AG. Inside the rolling window, George Simeon reported 1 open-market purchase totaling $17.1M in ADRX and 1 open-market sale totaling $720K in CRSP. The largest disclosed transaction in the window is a purchase of 1,007,407 ADRX shares on Sep 28, 2026, worth $17.1M.
Companies traded
Other insiders at CRSP
Insider Buying
$17.1M
reported purchases (SEC code P)
Insider Selling
$720K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has George Simeon made?
George Simeon has filed 2 SEC Form 4 filings (11 transaction rows) across 2 companies, including CRSP, ADRX since 2026.
Which companies does George Simeon trade?
George Simeon has filed SEC Form 4 disclosures for 2 companies, including CRSP, ADRX.
When was George Simeon's most recent SEC Form 4 filing?
George Simeon's most recent SEC Form 4 filing on Tracefour is dated Oct 16, 2026.
What is George Simeon's total buy and sell value in the current window?
Inside the rolling retention window, George Simeon bought $17.1M and sold $720K based on SEC Form 4 filings.
What was George Simeon's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,007,407 ADRX shares on 2026-09-28, worth $17.1M, per SEC Form 4 filings.